Quality Control Tariffs Active Pharmaceutical Ingredients Market Trends Domestic Production Supply Chain Biosimilars Active Ingredients Weight Loss Drugs Research and Development Medicare U.S. Drug Policy FDA Regulations U.S. Expansion Plans Specialty Drugs Diabetes Treatment Bulk Drug Imports Production Capacity Supply Chain Management Regulatory Issues Import Regulations Pricing Strategies Global Distribution Chemical Sourcing Novo Nordisk Trade Policies Regulatory Environment Drug Investment Controlled Substances Chronic Diseases U.S. Manufacturing Biologics Production Sales Performance GLP-1 Treatments Cost Management Price Regulation Drug Exports Small-Cap Companies Gene Therapy Production Strategies Fentanyl Production Laboratory Regulations
The upgrade positions the site to supply markets outside the U.S. ahead of a possible EMA decision on the Wegovy pill.
